Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to $2.1 million.

  • AC Immune's Net Cash Flow rose 11118.52% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.2 million, marking a year-over-year decrease of 19667.1%. This contributed to the annual value of -$46.3 million for FY2024, which is 18545.77% down from last year.
  • Latest data reveals that AC Immune reported Net Cash Flow of $2.1 million as of Q3 2025, which was up 11118.52% from $9.0 million recorded in Q2 2025.
  • AC Immune's Net Cash Flow's 5-year high stood at $54.0 million during Q4 2023, with a 5-year trough of -$51.2 million in Q2 2021.
  • Its 5-year average for Net Cash Flow is -$7.4 million, with a median of -$11.6 million in 2021.
  • In the last 5 years, AC Immune's Net Cash Flow tumbled by 140862.36% in 2021 and then skyrocketed by 51323.58% in 2023.
  • Over the past 5 years, AC Immune's Net Cash Flow (Quarter) stood at -$11.7 million in 2021, then decreased by 11.48% to -$13.1 million in 2022, then soared by 513.24% to $54.0 million in 2023, then plummeted by 95.96% to $2.2 million in 2024, then decreased by 2.93% to $2.1 million in 2025.
  • Its Net Cash Flow stands at $2.1 million for Q3 2025, versus $9.0 million for Q2 2025 and -$18.5 million for Q1 2025.